Candel Therapeutics, Inc., a clinical-stage biopharmaceutical company, is dedicated to the development of off-the-shelf viral immunotherapies for cancer treatment (Candel Therapeutics, Inc.). With no specific customer names provided in the text, the company operates in the biopharmaceutical industry, focusing on the development of viral immunotherapies to transform the lives of cancer patients. Candel Therapeutics' main business activities involve the creation of engineered viruses designed to induce a systemic anti-tumor response. This is achieved...
| S.No. | Ticker | Company | Market Cap | P/E | P/S | Total Debt (Qtr) |
|---|---|---|---|---|---|---|
| 1 | VRTX | Vertex Pharmaceuticals Inc / Ma | 110.91 Bn | 28.23 | 9.24 | - |
| 2 | ARGX | Argenx Se | 45.93 Bn | 33.41 | 1.22 | - |
| 3 | ALNY | Alnylam Pharmaceuticals, Inc. | 42.08 Bn | 151.38 | 13.36 | - |
| 4 | ZLAB | Zai Lab Ltd | 22.48 Bn | -127.00 | 92.73 | 0.20 Bn |
| 5 | RPRX | Royalty Pharma plc | 19.96 Bn | 27.11 | 8.39 | 8.95 Bn |
| 6 | ROIV | Roivant Sciences Ltd. | 19.94 Bn | -31.93 | 3,473.65 | - |
| 7 | RVMD | Revolution Medicines, Inc. | 19.51 Bn | -16.68 | 23,509.63 | - |
| 8 | MRNA | Moderna, Inc. | 19.18 Bn | -6.70 | 9.87 | 0.59 Bn |